Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Hineline Lawrence J. Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2023 4 Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.
Txns: Sold 34,227 shares @ $63.35, valued at $2.2M
Sold 44,035 shares @ $64.37, valued at $2.8M
Sold 3,592 shares @ $65.01, valued at $233.5k
Exercised 40,472 options to buy @ $53.63, valued at $2.2M
Exercised 25,082 options to buy @ $23.94, valued at $600.5k
Exercised 11,762 options to buy @ $36.89, valued at $433.9k
Exercised 4,538 options to buy @ $56.73, valued at $257.4k
03/13/2023 4 Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.
Txns: Granted 15,663 shares @ $0
Sold 12,963 shares @ $43.17, valued at $559.6k
Sold 2,700 shares @ $42.52, valued at $114.8k
Sold 5,324 shares @ $44.97, valued at $239.4k
Sold 258 shares @ $44.14, valued at $11.4k
Exercised 5,582 restricted stock units @ $0
03/08/2023 4 Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.
Txns: Granted 39,398 restricted stock units @ $0
02/27/2023 4 Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.
Txns: Sold 7,455 shares @ $47.03, valued at $350.6k
Exercised 7,455 restricted stock units @ $0
02/22/2023 4 Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.
Txns: Sold 52,279 shares @ $49.81, valued at $2.6M
Sold 1,689 shares @ $50.59, valued at $85.4k
Sold 8,649 shares @ $46.54, valued at $402.5k
Sold 800 shares @ $47.32, valued at $37.9k
Sold 900 shares @ $48.72, valued at $43.8k
Sold 94 shares @ $49.6, valued at $4.7k
Exercised 53,968 options to buy @ $12.73, valued at $687k
Exercised 10,443 restricted stock units @ $0
09/23/2022 4 Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.
Txns: Sold 31,861 shares @ $45.88, valued at $1.5M
Sold 33,303 shares @ $45.39, valued at $1.5M
Exercised 65,164 options to buy @ $15.47, valued at $1M
03/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/11/2022 4 Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.
Txns: Sold 3,105 shares @ $41.61, valued at $129.2k
Sold 12,434 shares @ $40.77, valued at $506.9k
Sold 4,100 shares @ $40.07, valued at $164.3k
Exercised 19,639 restricted stock units @ $0
12/23/2021 4 Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.
Txns: Sold 25,462 shares @ $48.67, valued at $1.2M
Sold 100,803 shares @ $47.84, valued at $4.8M
Sold 35,135 shares @ $46.91, valued at $1.6M
Sold 9,200 shares @ $45.81, valued at $421.5k
Sold 3,800 shares @ $44.95, valued at $170.8k
Sold 600 shares @ $44.28, valued at $26.6k
Exercised 50,000 options to buy @ $16.86, valued at $843k
Exercised 72,120 options to buy @ $17.57, valued at $1.3M
Exercised 52,880 options to buy @ $15.73, valued at $831.8k
02/25/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/13/2020 4 Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.
Txns: Sold 28,034 shares @ $25.41, valued at $712.3k
Exercised 10,000 options to buy @ $2.84, valued at $28.4k
Exercised 10,000 options to buy @ $3.26, valued at $32.6k
09/11/2020 4 Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.
Txns: Sold 41,983 shares @ $31.14, valued at $1.3M
Exercised 26,983 options to buy @ $12.73, valued at $343.5k
02/20/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/28/2020 4 Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.
Txns: Granted 8,043 shares @ $0
Disposed of 3,809 shares @ $23.61, valued at $89.9k
01/10/2020 4 Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.
Txns: Sold 19,638 shares @ $26.16, valued at $513.7k
01/08/2020 4 Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.
Txns: Sold 3,867 shares @ $29.8, valued at $115.2k
Sold 17,591 shares @ $30.4, valued at $534.8k
Exercised 19,638 restricted stock units @ $0
01/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/26/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/01/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/08/2019 4 Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.
Txns: Sold 19,716 shares @ $11.42, valued at $225.2k
Sold 1,742 shares @ $11.84, valued at $20.6k
Sold 3,108 shares @ $12.42, valued at $38.6k
Gifted 1,200 shares @ $0
Exercised 3,108 restricted stock units @ $0
Granted 80,951 options to buy @ $12.73, valued at $1M
Granted 58,915 restricted stock units @ $0
01/03/2019 4 Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.
Txns: Granted 7,807 shares @ $0
Sold 7,807 shares @ $11.09, valued at $86.6k
Exercised 5,298 restricted stock units @ $0
Exercised 16,160 restricted stock units @ $0
02/20/2018 4 Hineline Lawrence J. (VP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.
Txns: Sold 33,381 shares @ $20.03, valued at $668.6k
Sold 16,319 shares @ $20.01, valued at $326.5k
01/05/2018 4 Hineline Lawrence J. (VP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.
Txns: Sold 3,192 shares @ $15.67, valued at $50k
Sold 1,870 shares @ $17.49, valued at $32.7k
Exercised 5,297 restricted stock units @ $0
Exercised 3,108 restricted stock units @ $0
Granted 65,164 options to buy @ $15.47, valued at $1M
Granted 48,480 restricted stock units @ $0
01/09/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy